Just squirting around the Ihub boards and here's a recent summary of the soap opera-ish developments of Elite Pharma. Lots of waiting and a decreased PPS allows for a lot of drama on both sides of the prospective outlook on the company. And while on paper, and on the C.C. with top management, the company appears poised for prosperity, there are plenty of naysayers offering bashlines that haven't faded. A lot of investors felt that at the .07 range, the company would be well priced for a public takeover, but there's not much to go on to substantiate this to be in the interest of the co. or its investors. Indeed with such a mighty strong looking pipeline, and recent news, the PPS would have shot up to challenge the .25 range we remember from a couple years back. The gamble is that any of the available speculation should be considered, and there's a lot to sift through if you can handle a hefty load of garbage filler posts. Be ready for anything, ELTP is loading the boat on hope and pipeline, see if it runs.
Aqua Says: I'm certain with the 8 commercial and partnered drugs, 2 ADT/ART patents, record breaking earnings in company history, LPC financing, and clinical trials starting by the end of this year that Jerry and his team are building a super hot rod company. Cheers!
Big Green 101 says: If I was to get investors involved in ELTP, I would focus on 1) the multi-products the they have and 2) Revenues - (they) appear to be growing. (Still cautious on the point of growth which will be known in the next reporting period soon.)
Tangerine says: How many OTC companies have numerous FDA approved drugs? Have record revenues, far exceeding what most thought they would be? Drive positive cash ? The numbers are speaking for themselves at this point...
Or what is really amazing is how many drug companies have what 8 drug companies as partners in the business on various products including the development of both generic and branded products for them...
All these drugs bring revenue and its obvious some are really settling into a groove. Some are still pretty new and we have three more approved not even incuded in those revenues. And generic of half of Qysmia should do very very well as should Naltrexone.
And another dozen in the pipeline - that is a fact.
Dr. Lowenstein says: Lol lol all that and a 7 penny.
B_MT says: 8 FDA approved products, $10 million line of credit, awarded two patents for ART/ ADT tech,human trials by year's end, highest quarterly revenue in company history......THAT IS PROGRESS!
Tangerine also added: I have given you the numbers many times. In the Q for sept 2011, the fully diluted count was at 454m. This includes all the warrants, milestone shares, preferred. It is now at about 527 with LPC deal. For all these shares to come to light, that would mean the following
1)All the warrants converted - lots of cash to Elite
2) All the EPIC drugs were filed and approved - Pretty much straight profit to Elite forever, and warrant conversions....again lots of cash
3)Preferred converted which means the little remaining finance dilution from old bad deals is completely over. Almost over now
4)We cashed in all the LPC funds to fund many trials and studies - However if all the warrants cashed out, we wouldn't need this money would we? So you can't really claim both.
And this doesn't include Novel which changes everything
And if all these things happened and all these shares came to light and lets say the number was at 500m....(old warrants will be coming off) the market cap at the current PPS would be about 40m dollars.
I have a current value on Elite of about 125m dollars now. You think with 20-25 drugs bringing in revenue, all the studies and ADT products, all the other products and partnerships that would come in this timeline, the company would only be worth 40m dollars? It would be worth a lot more then that without the abuse deterrent products!!!!
Lets be real here. The is ridiculously undervalued as it is. Add all those other items and what is the company worth? And for all these shares to come to light I think we are in the 15-20m in cash range. You have any idea how many products they could develop with that cash?
And this still doesn't include Novel
Aqua Says: I'm certain with the 8 commercial and partnered drugs, 2 ADT/ART patents, record breaking earnings in company history, LPC financing, and clinical trials starting by the end of this year that Jerry and his team are building a super hot rod company. Cheers!
Big Green 101 says: If I was to get investors involved in ELTP, I would focus on 1) the multi-products the they have and 2) Revenues - (they) appear to be growing. (Still cautious on the point of growth which will be known in the next reporting period soon.)
Tangerine says: How many OTC companies have numerous FDA approved drugs? Have record revenues, far exceeding what most thought they would be? Drive positive cash ? The numbers are speaking for themselves at this point...
Or what is really amazing is how many drug companies have what 8 drug companies as partners in the business on various products including the development of both generic and branded products for them...
All these drugs bring revenue and its obvious some are really settling into a groove. Some are still pretty new and we have three more approved not even incuded in those revenues. And generic of half of Qysmia should do very very well as should Naltrexone.
And another dozen in the pipeline - that is a fact.
Dr. Lowenstein says: Lol lol all that and a 7 penny.
B_MT says: 8 FDA approved products, $10 million line of credit, awarded two patents for ART/ ADT tech,human trials by year's end, highest quarterly revenue in company history......THAT IS PROGRESS!
Tangerine also added: I have given you the numbers many times. In the Q for sept 2011, the fully diluted count was at 454m. This includes all the warrants, milestone shares, preferred. It is now at about 527 with LPC deal. For all these shares to come to light, that would mean the following
1)All the warrants converted - lots of cash to Elite
2) All the EPIC drugs were filed and approved - Pretty much straight profit to Elite forever, and warrant conversions....again lots of cash
3)Preferred converted which means the little remaining finance dilution from old bad deals is completely over. Almost over now
4)We cashed in all the LPC funds to fund many trials and studies - However if all the warrants cashed out, we wouldn't need this money would we? So you can't really claim both.
And this doesn't include Novel which changes everything
And if all these things happened and all these shares came to light and lets say the number was at 500m....(old warrants will be coming off) the market cap at the current PPS would be about 40m dollars.
I have a current value on Elite of about 125m dollars now. You think with 20-25 drugs bringing in revenue, all the studies and ADT products, all the other products and partnerships that would come in this timeline, the company would only be worth 40m dollars? It would be worth a lot more then that without the abuse deterrent products!!!!
Lets be real here. The is ridiculously undervalued as it is. Add all those other items and what is the company worth? And for all these shares to come to light I think we are in the 15-20m in cash range. You have any idea how many products they could develop with that cash?
And this still doesn't include Novel
